ZA955193B - A cosmetic or medical composition for topical application to the skin - Google Patents

A cosmetic or medical composition for topical application to the skin

Info

Publication number
ZA955193B
ZA955193B ZA955193A ZA955193A ZA955193B ZA 955193 B ZA955193 B ZA 955193B ZA 955193 A ZA955193 A ZA 955193A ZA 955193 A ZA955193 A ZA 955193A ZA 955193 B ZA955193 B ZA 955193B
Authority
ZA
South Africa
Prior art keywords
cosmetic
skin
topical application
medical composition
medical
Prior art date
Application number
ZA955193A
Other languages
English (en)
Inventor
Elka Touitou
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23005031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA955193(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of ZA955193B publication Critical patent/ZA955193B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ZA955193A 1994-06-22 1995-06-22 A cosmetic or medical composition for topical application to the skin ZA955193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/264,204 US5540934A (en) 1994-06-22 1994-06-22 Compositions for applying active substances to or through the skin

Publications (1)

Publication Number Publication Date
ZA955193B true ZA955193B (en) 1997-03-24

Family

ID=23005031

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955193A ZA955193B (en) 1994-06-22 1995-06-22 A cosmetic or medical composition for topical application to the skin

Country Status (8)

Country Link
US (2) US5540934A (xx)
EP (1) EP0804160B2 (xx)
AU (1) AU2977695A (xx)
CA (1) CA2193359A1 (xx)
DE (1) DE69512685T3 (xx)
IL (1) IL114229A (xx)
WO (1) WO1995035095A1 (xx)
ZA (1) ZA955193B (xx)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447684A (en) * 1988-10-03 1995-09-05 Williams; Robert M. Sterilization devices, sporicidal compositions, sterilization methods, and devices for reducing surface tension
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
AU2588297A (en) * 1996-04-04 1997-10-29 Ortho Pharmaceutical Corporation Liposome-based topical vitamin d formulation
WO1998002184A1 (de) * 1996-07-13 1998-01-22 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Topische phospholipidhaltige aciclovirzubereitung
GB9618974D0 (en) * 1996-09-11 1996-10-23 Glaxo Group Ltd Medicaments
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
AU5777498A (en) * 1997-01-13 1998-08-03 Cilag A.G. Liposome-based topical tretinoin formulation
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
US6132762A (en) * 1997-05-05 2000-10-17 Cristobal; Walter Transcutaneous application of marijuana
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
DE69825495T2 (de) 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
ATE216223T1 (de) 1999-01-27 2002-05-15 Idea Ag Transnasaler transport bzw. impfung mit hochadaptierbaren trägern
ATE216875T1 (de) 1999-01-27 2002-05-15 Idea Ag Nichtinvasive impfung durch die haut
GB9902527D0 (en) * 1999-02-04 1999-03-24 Phares Pharm Res Nv Compositions
WO2000051553A1 (en) * 1999-03-01 2000-09-08 The General Hospital Corporation An anti-reflective cosmetic composition for reducing the visibility of wrinkles
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
EP1109533A1 (en) * 1999-07-08 2001-06-27 Orlando Hung Pulmonary delivery of liposome-encapsulated cannabinoids
KR20020020274A (ko) * 1999-08-18 2002-03-14 히라타 다다시 육모제
US6747058B1 (en) * 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US7648696B2 (en) * 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
WO2002011768A1 (en) 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US7442369B1 (en) * 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
DE10296335T5 (de) 2001-02-14 2004-04-15 G W Pharma Ltd., Salisbury Pharmazeutische Formulierungen
US10004684B2 (en) 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
CA2452088A1 (en) * 2001-06-26 2003-01-03 Elka Touitou Compositions and methods for intracellular delivery
NZ534142A (en) * 2002-01-21 2007-08-31 Vasogen Ireland Ltd Pharmaceutically acceptable phosphate-glycerol carrying bodies comprising phospatidylglycerol and/or phosphatidylcholine and/or phosphatidylglycerol
DE10203923B4 (de) * 2002-01-31 2011-06-01 Klinipharm Gmbh Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
US7105173B1 (en) 2002-03-21 2006-09-12 Rolling Kenneth J Nicotine replacement applique
CN101455649B (zh) * 2002-06-10 2014-02-26 欧洲凯尔特公司 防止所含活性剂被误用的经皮给药器的处置系统
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
DK1530469T3 (da) * 2002-08-20 2009-05-04 Euro Celtique Sa Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
AU2003301174A1 (en) * 2002-12-20 2004-07-22 Idexx Laboratories, Inc. Liposomal analgesic formulation and use
DK1594456T3 (da) * 2003-01-20 2009-01-19 Auriga Internat S A Anvendelse af en sammensætning indeholdende vitamin K1-oxid eller et derivat deraf til behandling og/eller forebyggelse af dermatologiske læsioner hos pattedyr
DE10308852A1 (de) * 2003-02-27 2004-09-09 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Mittel gegen Faltenbildung der Haut
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
SE0400235D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New composition containing quinoline compounds
WO2005094790A1 (es) * 2004-04-02 2005-10-13 Italfarmaco, S.A. Formulaciones liposomales
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2006043788A1 (en) * 2004-10-20 2006-04-27 Doosan Corporation Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine
KR20070086045A (ko) * 2004-11-12 2007-08-27 이데아 아게 피부 상태 치료에서의 확대된 표면 집합체
US8808715B1 (en) 2004-11-23 2014-08-19 Georgia Regents Research Institute, Inc Methods and compositions for modulating keratinocyte function
JP2008521818A (ja) * 2004-11-23 2008-06-26 メデイカル・カレツジ・オブ・ジヨージア ケラチノサイト機能を調節するための方法および組成物
EP1849481A4 (en) * 2005-01-07 2012-11-28 Rohto Pharma COMPOSITION FOR TOPICAL APPLICATION
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
ES2385513T3 (es) * 2005-10-11 2012-07-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Composición para administración nasal
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
SI1937642T1 (sl) * 2005-10-19 2015-01-30 Teva Pharmaceutical Industries Ltd. Kristali natrijevega lakvinimoda in postopek za njihovo pripravo
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
WO2008005045A2 (en) * 2005-12-30 2008-01-10 Dermazone Solutions, Inc. Nanolipidic particles
NZ571460A (en) * 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
ATE532515T1 (de) 2006-06-12 2011-11-15 Teva Pharma Stabile laquinimod-zubereitungen
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
RU2009117468A (ru) * 2006-10-12 2010-11-20 Рото Фармасьютикал Ко., Лтд. (Jp) Наружный препарат для кожи
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
ES2600920T3 (es) 2007-12-20 2017-02-13 Teva Pharmaceutical Industries, Ltd. Preparaciones estables de laquinimod
CN104311486A (zh) * 2008-09-03 2015-01-28 泰华制药工业有限公司 2-羰基-1,2-二氢喹啉免疫功能调节剂
MX2011003207A (es) * 2008-09-27 2011-11-04 Jina Pharmaceuticals Inc Preparaciones farmaceuticas a base de lipidos para la aplicacion oral y topica; sus composiciones, metodos y usos.
EP2391208A4 (en) 2009-01-30 2012-09-12 Yissum Res Dev Co COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
WO2010086727A1 (en) * 2009-01-30 2010-08-05 Galderma Pharma Sa Stable compositions for nail onychomycosis treatment
IT1398268B1 (it) 2009-03-10 2013-02-22 Prigen Srl Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico
KR20120045032A (ko) * 2009-07-30 2012-05-08 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드를 이용한 크론병의 치료
DK2467372T3 (en) * 2009-08-10 2016-08-22 Teva Pharma TREATMENT OF BDNF-RELATED DISEASES USING LAQUINIMOD
FR2950807B1 (fr) * 2009-10-06 2012-02-03 Lvmh Rech Composition cosmetique contenant des liposomes encapsules dans un compose oxazolidin-2-one
HUE057866T2 (hu) 2009-11-03 2022-06-28 Lipidor Ab Lipid réteget képzõ kompozíció egy élõ organizmus felületére történõ alkalmazásra
WO2011064769A1 (en) 2009-11-24 2011-06-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and pharmaceutical compositions for the treatment of hot flashes
US8470833B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
EP2542079B1 (en) * 2010-03-03 2014-05-21 Teva Pharmaceutical Industries Ltd. Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
KR20130006640A (ko) * 2010-03-03 2013-01-17 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드를 이용한 루푸스 신장염의 치료
PT2542080T (pt) * 2010-03-03 2016-11-16 Teva Pharma Tratamento de artrite causada por lúpus usando laquinimod
DE102010013064A1 (de) 2010-03-26 2011-12-15 Gabriele Blume Neuartiges Trägersystem für den Transport von Wirkstoffen in die Haut
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
CN102133183B (zh) * 2011-03-04 2012-02-29 湘潭大学 一种阿昔洛韦醇质体及其制备方法
CN102406605A (zh) * 2011-04-28 2012-04-11 辽宁省计划生育科学研究院 雄性激素类药物的醇质体制剂及其制备方法
CN106344576A (zh) 2011-10-12 2017-01-25 泰华制药工业有限公司 以拉喹莫德和芬戈莫德的组合治疗多发性硬化症
CN102397255B (zh) * 2011-11-24 2013-06-26 广东药学院 一种黄体酮醇质体及其制备方法与应用
EP2811832A4 (en) 2012-02-03 2015-09-23 Teva Pharma USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH MORBUS CROHN AFTER FAILED PREVIOUS ANTI-TNF THERAPY
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
EA201590788A1 (ru) 2012-11-07 2015-12-30 Тева Фармасьютикал Индастриз Лтд. Аминные соли лахинимода
DE102012025485A1 (de) 2012-12-20 2014-06-26 Gabriele Blume Neuartige Vesikel für die topische Anwendung in der Pharmazie und Kosmetik
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
CA2906594C (en) * 2013-03-15 2019-01-08 Leading Edge Innovations, LLC Substantially surfactant-free, submicron dispersions of hydrophobic agents containing high levels of water miscible solvent
US20140322428A1 (en) 2013-03-15 2014-10-30 Leading Edge Innovations, LLC Compositions having an oil-in-water dispersion of submicron particles to enhance foods and beverages
WO2014184173A1 (en) * 2013-05-14 2014-11-20 Montero Gida Sanayi Ve Ticaret A.S. Hair care formulations
TWM473835U (zh) * 2013-05-15 2014-03-11 Wu xu sheng 微米牛樟芝微脂載體結構
US20170172922A1 (en) * 2013-05-15 2017-06-22 Hsu-Shen WU Micron taiwanofungus camphoratus liposome structure
EP3038596B1 (en) 2013-08-30 2020-01-08 Dalhousie University Compositions and methods for the removal of tattoos
US20150147382A1 (en) * 2013-09-23 2015-05-28 Exir Nano Sina Company Topical liposomal compositions for delivering hydrophobic drugs and methods preparing same
US10137079B2 (en) * 2014-02-20 2018-11-27 Cura Health Inc. Transdermal composition for treating pain
AU2015253330A1 (en) 2014-04-29 2016-12-01 Teva Pharmaceutical Industries Ltd. Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status
US10765817B2 (en) 2014-08-13 2020-09-08 Elwha, Llc Methods, systems, and devices related to delivery of alcohol with an inhaler
US10245393B2 (en) 2014-08-13 2019-04-02 Elwha Llc Methods, systems, and devices related to a supplemental inhaler
US10987048B2 (en) 2014-08-13 2021-04-27 Elwha Llc Systems, methods, and devices to incentivize inhaler use
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
US9375417B2 (en) 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
TWM513697U (zh) * 2015-06-26 2015-12-11 Ma Shen Kai Ruei Co Ltd 仿生物間質系統的載體結構
CN105380905A (zh) * 2015-12-17 2016-03-09 重庆医科大学附属永川医院 一种sod醇质体及其制备方法
US11147777B1 (en) 2017-06-16 2021-10-19 Charlotte's Web, Inc. Methods and formulations for efficacious pain relief by transdermal delivery of cannabidiol
KR101810160B1 (ko) * 2017-06-30 2018-01-25 주식회사 셀리제코스메틱 생리활성물질이 봉입된 에토좀 제조 방법, 에토좀 조성물 및 에토좀 조성물을 포함하는 화장료 조성물
WO2019087084A1 (en) 2017-11-02 2019-05-09 Eman Biodiscoveries Sd. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof
US20200078427A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery
US20200188298A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method For Using Composition With Enhanced Passenger Molecule Loading
US20200345609A1 (en) * 2019-04-30 2020-11-05 L'oreal Photostable antioxidant cosmetic composition
CN110664806B (zh) * 2019-10-17 2023-02-28 广东省农业科学院动物卫生研究所 一种非泼罗尼与甲氧普烯二元醇质体及其制备方法和应用
CN115737561A (zh) * 2022-09-16 2023-03-07 北京市中医药研究所 复方二元醇质体、其制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
JPS5910511A (ja) † 1982-07-07 1984-01-20 Eisai Co Ltd 脂溶性物質含有水性液
JPS607932A (ja) † 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
EP0177223B1 (en) * 1984-09-24 1990-02-28 Michael Mezei Pharmaceutical multi-phase composition
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US4994213A (en) * 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
ES2060365T3 (es) * 1990-02-08 1994-11-16 Nattermann A & Cie Composicion acuosa de fosfolipidos en forma de gel que contiene alcohol, su utilizacion y preparaciones topicas que la contienen.
GB9108043D0 (en) * 1991-04-16 1991-06-05 Phares Pharm Res Nv Method for the formation of liposomes and compositions for use therein
EP0582239B1 (de) * 1992-08-04 1999-08-04 Rhone-Poulenc Rorer Gmbh Pharmazeutische und/oder kosmetische Zubereitung
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin

Also Published As

Publication number Publication date
EP0804160B2 (en) 2004-05-06
AU2977695A (en) 1996-01-15
US5716638A (en) 1998-02-10
WO1995035095A1 (en) 1995-12-28
IL114229A0 (en) 1995-10-31
IL114229A (en) 1999-05-09
US5540934A (en) 1996-07-30
EP0804160A1 (en) 1997-11-05
DE69512685T2 (de) 2000-05-11
DE69512685D1 (de) 1999-11-11
CA2193359A1 (en) 1995-12-28
EP0804160B1 (en) 1999-10-06
DE69512685T3 (de) 2005-02-10

Similar Documents

Publication Publication Date Title
ZA955193B (en) A cosmetic or medical composition for topical application to the skin
IL112649A (en) Topically effective compositions for application to the skin or hair
GB9422260D0 (en) Improvements relating to skin prickers
HUP9904677A3 (en) Cosmetic composition for skin care
EP0796077A4 (en) REVITALIZING MAKEUP COMPOSITION
IL109012A0 (en) Skin whitening composition
ZA958445B (en) Compositions for topical application to skin hair and nails
GB9604673D0 (en) Skin care compositions
GB9319104D0 (en) Skin care method & composition
ZA952356B (en) Skin treatment composition
ZA964552B (en) Compositions for topical application to skin.
GB9604674D0 (en) Skin care compositions
AU4868396A (en) Skin care composition
EP0466410A3 (en) Occlusive skin cosmetic composition
PL338337A1 (en) Skin care composition
GB9616953D0 (en) Improvements relating to skin prickers
ZA9810799B (en) Skin care composition
AU6388494A (en) Skin care composition
AU1892395A (en) Skin cleansing composition
GB9423974D0 (en) Skin care compositions
ZA952121B (en) Skin treatment composition
PL311915A1 (en) Pharmaceutic, dermatological and cosmetic composition
ZA952120B (en) Skin treatment composition
GB9319103D0 (en) Skin care method & composition
IL113487A0 (en) Topical preparation for application to the skin